论文部分内容阅读
1960年,Mammen等首先报告,在体外用凝血酶处理一组与维生素K密切有关的血浆蛋白后,可产生明显的抗凝血活性,并把这种具抗凝血特性的物质称为“自体凝血酶原Ⅱ—A(AutoprothrombinⅡ—A,APⅡ—A)”.其后Wetmore等(1974)的体内实验
In 1960, Mammen et al. First reported that in vitro treatment of a group of plasma proteins closely related to vitamin K with thrombin produces significant anticoagulant activity and refers to this substance with anticoagulant properties as “ AutoprothrombinⅡ-A (APⅡ-A) ”. Then Wetmore et al. (1974) in vivo experiments